Adaptive Biotechnologies
Anna Sherwood is an accomplished professional with extensive experience in research and development, currently serving as VP of Research and Development at Adaptive Biotechnologies Corp. since August 2010. Sherwood manages a diverse team of 26 individuals focused on inventing and developing new immunosequencing assays for both research and clinical applications. Previously, Sherwood built and expanded the Seattle Research and Development Team, overseeing the development and release of nine assays. Academic credentials include a Ph.D. in Plant Biology from the University of California, Davis, and a B.S. in Biology from Washington State University. Sherwood has also gained valuable experience as a Postdoctoral Fellow at Jasieniuk Lab, a Research Assistant at Nickerson Lab, and a Lab Technician with the Peace Corps.
This person is not in any teams
This person is not in any offices
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.